Eco GEO Insights

Eco-GEO: Branding for the 0-1 cold-start phase of medical aesthetics GEO: Let AI verify first before discussing citation

The first summary given by AI might be the potential customer’s first impression of medical beauty institutions. This article breaks down how to unify brand facts, settle terminology, and develop methodologies during the cold start period from a white-hat GEO perspective, and uses actionable observation indicators instead of ranking thinking.

Eco-GEO: Branding for the 0-1 cold-start phase of medical aesthetics GEO: Let AI verify first before discussing citation
Edited and fact-checked by Eco GEO Research Desk. This article follows the Eco GEO editorial policy.

For the market leaders in medical aesthetics during the 0-1 cold start period, the core conclusion of this article is: The first step in brand development is not to seize a dominant position, but to turn brand facts into expressions that can be verified and absorbed by AI. Three key points:

  • Being selected and being actually adopted are two different things. A page must first be indexable and appear as a supporting link before it can be considered part of the answers. Whether it will contribute definitions, values, or steps after entering the answers depends on the evidence density and semantic fit of the content. [S1][S2]
  • The medical aesthetics industry has specific legal constraints: commitments related to treatment outcomes or safety guarantees, statements made in the name of “recommendation officers” or “experience officers,” and comparisons of patients’ outcomes before and after are key targets for enforcement. Such content should not be used as brand facts, neither for SEO nor GEO purposes. [S3]
  • During the cold start period, the actions that can be taken are minimal: create a list of facts, set a set of target questions, and manually record the incorrect brand summaries in AI responses. This is more informative than arguing about whether to do GEO or not.

Scope of Application and Limitations: This article is targeted at medical beauty industry teams in mainland China that are in the 0-1 cold start phase. It discusses the organization of public information and does not cover budget allocation, channel selection, or sales tactics.

Three limitations need to be noted.First, the platform documents and papers cited are general search-side materials and do not contain data on the customer acquisition cycle, conversion rate, or GEO results in the medical aesthetics industry. Therefore, this article makes no estimates regarding “how much consultation can be generated from these efforts.”Secondly, the conclusions of the paper come from a controlled trial set and public datasets, which are descriptive observations. The authors explicitly state that they do not make causal inferences, and these findings cannot be directly extrapolated to the real-world marketing environment of medical aesthetics.[S2]Thirdly, the regulatory section serves only as a compliance reminder. Whether a specific piece of information constitutes medical advertising or requires review approval must be determined by the institution’s legal department or local regulatory authorities. This article does not constitute legal advice.

I. Why it’s even more important to discuss “being correctly understood” during the cold start period

In the medical aesthetics decision-making process, potential customers often ask very short questions to AI: “Is this institution reliable for such projects?” “What exactly is a certain project?” “What qualifications are required?” The summary statement returned by AI may be the customer’s first impression of the brand. If the institution name, the range of projects it can carry out, or professional information in this statement is incorrect, this mistake may be reused in subsequent responses.

From a platform mechanism perspective, AI Overviews and AI Mode initiate multiple related searches for sub-topics and data sources through a process called “query fan-out,” before combining the results to form an answer. [S1] This means that brand information may be pieced together from multiple sources, and any inconsistency in the information from one source could become part of the final answer.

Therefore, the core judgment of this article is that the underlying logic of branded GEO during its cold start phase is not to rank products, but rather to enable AI to understand, verify, and cite brand-standard expressions based on evidence. This order cannot be reversed—first solve the issue of “being indexable and verifiable,” then discuss “being incorporated into answers.”

II. The ≠ that can be selected has been absorbed: Where does the focus of the white-hat approach lie?

A study based on 602 controlled prompts and 21,143 valid retrieval layer citation records divides GEO into two stages: citation selection (the platform initiates the search and selects sources) and citation absorption (whether the cited pages actually contribute language, evidence, structure, or factual support). The descriptive results of this study show that platforms differ significantly in citation breadth and depth. High-impact pages tend to be longer, more modular, semantically consistent with generated answers, and are more likely to contain extractable types of evidence, such as definitions, numerical facts, comparisons, and step-by-step instructions. [S2]

One negative finding from this study that’s useful for content teams is that simply changing the content into a Q&A format doesn’t improve its absorption rate. The average impact of the Q&A pages in the research report was even slightly lower than that of non-Q&A pages. [S2] suggests that we should focus on structure and evidence rather than just using a FAQ template. It’s important to note that this is a descriptive conclusion under controlled conditions and cannot be equated with the actual results of medical beauty campaigns.

The requirements on the platform technology side are relatively simple: the page must be indexable and eligible to display summaries, so it can appear as a support link. The official guidelines clearly state that there are no additional technical barriers.[S1]So, during the cold start period, white-hat actions still start with basic tasks such as capturing and releasing data, internal linking, text representation, and aligning structured data with visible text. [S1]

At the interface level of generative search, the platform’s public statements also emphasize the need to cite verifiable sources. For example, Bing describes Copilot Search as “citing its sources prominently” and lists all the links used to generate the response. [S4] This is the platform’s self-description; it’s not an independent measurement, but it indicates that “verifiable” is a key design goal. It’s also important to note that this service explicitly does not include mainland China. [S4]

III. Consistency is the most difficult and valuable step for medical beauty brands

Information about medical beauty institutions is naturally scattered: official websites, official accounts, platform stores, maps and business information, and offline materials. For branded GEO requirements, the names of these institutions, their licensing qualifications, the range of services they offer, physician information, and their external presentations must all be consistent. This is not just a SEO issue, but also a compliance issue.

According to the “Guidelines for Law Enforcement in Medical Beauty Advertising” issued by the State Administration for Market Regulation, medical beauty advertising is considered medical advertising. Advertisers must obtain a practicing license from medical institutions in accordance with the law. Additionally, they must obtain a “Medical Advertising Review Certificate” before publishing advertisements, and they must publish content in accordance with the approved guidelines. [S3] These guidelines also list situations where it is important to crack down on: promoting treatment outcomes, making guarantees regarding safety and efficacy, using patients’ names or images to compare treatment effects before and after treatment, and using terms like “recommendation officers” or “experience officers” to make promotional claims. [S3]

Here’s a key boundary for cold-launching brands: Beauty medical institutions must actively disclose service information in accordance with regulations such as the Consumer Rights Protection Law and the E-commerce Law, but this disclosure is non-commercial in nature and generally not considered commercial advertising. The guideline [S3] reminds us that separating “verifiable institutional and service information” from “promotional statements with commitments” is a practical and risk-minimizing approach. Whether specific content falls under this category still requires professional judgment on a case-by-case basis.

In other words, in the context of medical aesthetics, compliance constraints themselves determine which “facts” cannot be used as marketing messaging. This makes consistency easier to implement: make publicly available and verifiable parts into a set of standard expressions, while removing high-risk expressions from the brand vocabulary.

IV. Condensed Brand Terminology, Methodology, and Differentiated Expressions

The form of brand assets in the AI context has evolved from a simple Logo and slogan to a set of structured expressions that can be read by machines. In line with previous research on “evidence density being superior to question-and-answer formats,” it’s worth prioritizing the development of three types of content during the cold start phase:

  • Definition class: The standard way of writing organization names, the proper way of stating project names, and the accurate terminology for each stage in the service process. Definitions are one of the forms of evidence most easily absorbed by answers. [S2]
  • Step category: A clear public process description from appointment to postoperative follow-up. This type of content has clear boundaries and can be verified; no need to alter the effect descriptions.
  • includes verifiable facts such as qualification numbers, licensing information, and physician practice details, presented in a structured manner that matches the visible text on the page. [S1]

Differentiation doesn’t have to rely on adjectives.In the characteristic observations of controlled studies, numerical facts, comparisons, and definitions are types of evidence that are easier to extract, and these can indeed be organized using public information.[S2] It should be noted that the paper itself does not claim that content characteristics will deterministically affect citation results. We simply use it as a reference for prioritizing arrangement.

V. Action list and observation indicators during the 0-1 cold start period

These are actions that can be implemented within a few weeks without relying on additional budgetary resources:

  1. Create a brand fact ledger. Record institutional qualifications, scope of projects that can be carried out, and public statements item by item. Indicate the source and responsible person, and note which statements are high-risk and must not be used externally. [S3]
  2. Perform cross-channel consistency checks. List the conflicting statements between the official website and various platforms, and make them consistent within a specified timeframe.
  3. Please have legal or compliance review of the external content, removing statements such as guarantees, comparisons before and after, and expressions made in the name of recommenders or experience reviewers. [S3]
  4. Check basic technical items: whether the capture is allowed, whether important content is in text form, and whether structured data matches visible text. [S1]
  5. Fix a set of target questions (for example, ten to twenty natural language questions related to institutions, projects, or qualifications), and regularly manually sample and record the responses.

In terms of metrics, it is recommended to abandon “number of mentions” and instead use two more interpretable observations: one is the change in the number of cases where “brand information was correctly stated” in the sample questions; the other is the change in the number of cases where “clearly incorrect summaries appeared”. Both can be counted manually without the need for any tools.

Here, we can use a simple example to check the unit definitions and clarify the metric standards. Suppose there are 20 questions, with sampling done every two weeks. In the first phase, 14 questions had answers consistent with the ledger records, 3 had incorrect summaries, and 3 did not mention any brands. In the second phase, these numbers were 17, 1, and 2, respectively. This shows that the accuracy rate increased from 70% to 85%, while the number of incorrect summaries decreased from 3 to 1. These figures are based on our own sampling, and do not represent guarantees from the platform or all users. The sample size is small, so fluctuations are common; this should only be used to observe trends, and no conclusions should be drawn about the effectiveness of certain changes.

It should also be noted that the official documentation states that traffic from sites within AI functions will be included in the overall search traffic reported by Search Console and counted by web search type. Therefore, there is no need to establish a separate attribution framework for AI sources that cannot be verified. [S1]

VI. Parts that require no immediate judgment

There are several things that the current materials cannot answer. It is recommended to mark them as unknown during internal discussions instead of filling in assumptions: the actual proportion of medical beauty users who ask questions through AI searches and make decisions based on those responses, as well as the conversion paths involved; the incidence of incorrect summaries by AI answers regarding medical beauty brands; the customer acquisition effectiveness after being cited by AI; and the accessibility and display differences across generative platforms in mainland China (Bing was explicitly excluded from mainland China in the materials read). [S4] These blanks represent first-hand observations that can be accumulated during the cold start period, provided that the recording methods are consistent and the information is publicly disclosed.

In terms of implementation, brand-oriented GEO in the 0-1 stage is not a ranking competition, but rather a process of organizing brand facts. It involves unifying standards, structuring verifiable information, removing high-risk statements, and then verifying through quantitative but cautious sampling observations. This is what can be done on its own during the cold start period, and it’s also the part that’s least likely to go wrong.

Sources and Methodology

This analysis draws on the retrieved source text below. External facts, analytical inferences and illustrative assumptions are distinguished in the article; findings are bounded by their market, sample and date.

  1. [S1] AI Features and Your Website | Google Search Central  |  Documentation  |  Google for Developers — Google Search Central · Retrieved 2026-10-16
  2. [S2] From Citation Selection to Citation Absorption: A Measurement Framework for Generative Engine Optimization Across AI Search Platforms — arXiv authors · Retrieved 2026-10-16
  3. [S3] 市场监管总局关于发布《医疗美容广告执法指南》的公告 — State Administration for Market Regulation · Retrieved 2026-10-16
  4. [S4] Introducing Copilot Search in Bing — Microsoft Bing · Retrieved 2026-10-16
  5. [S5] Reimagining Discoverability: How Generative Engines Bring the Web to You — BCG · Retrieved 2026-10-16
GEO branded GEO White Hat GEO AI search medical aesthetics brand equity and AI citation

Related reading

AIBE quick checkCheck your brand visibility and citation risks in AI answers
Send inquiry